<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Mol Biochem Parasitol. 2013 July ; 190(1): 44&#226;&#8364;&#8220;49. doi:10.1016/j.molbiopara.2013.05.002. <br />  <br />  <br />  <br />                            Identification Essential Non-essential Protein Kinases by <br />                            Fusion PCR Method Efficient Production Transgenic <br />                            Trypanosoma brucei <br />                            Christopher Merritt Kenneth Stuart1 <br />                            Seattle Biomedical Research Institute, Seattle, WA 98109, USA <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                  Manipulation gene expression used elucidate gene function, explore fundamental <br />                                  biological processes identify potential drug targets Trypanosoma brucei. We in <br />                                  bloodstream forms CDC2-related kinase CRK12 (Tb11.01.4130) essential since <br />                                  transcriptional inactivation conditional <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span>null mutants</span> lethal 19 protein kinases not <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  essential null mutants viable. We did using efficient methods generation null <br />                                  conditional null cell lines T. brucei approaches generate transfection constructs with <br />                                  large targeting sequences use reliable transfection selection conditions. These <br />                                  methods, described in supplementary material, employ multiple <br />                                  oligonucleotides PCR reactions transfections cost effective can <br />                                  simultaneously generate 24 transfectants shifting rate limiting experimental steps the <br />                                  production cell lines analysis. <br />  <br />  <br />                            Keywords <br />                                  Trypanosoma brucei; Protein kinases; Gene <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span>knockout</span>; Conditional expression; Fusion PCR <br />                                  Method <br />  <br />                                             Manipulation gene expression powerful tool elucidating functions genes in <br />                                             context biological assessing potential gene products as <br />                                             drug targets. The functions numerous genes examined Trypanosoma brucei <br />                                             order explore fundamental biological processes search drug targets. In <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             addition, diploid protozoan extracellular pathogen served experimental <br />                                             surrogate related intracellular kinetoplastid pathogens T. cruzi Leishmania <br />                                             highly homologous syntenic genomes experimental genetic <br />                                             manipulation developed T. brucei [1]. <br />  <br />                                             The robust homologous recombination naturally present T. brucei been <br />                                             exploited make gene knockouts (KOs) genome modifications. For gene KOs, <br />                                             cells transfected electroporation linear DNA construct contains an <br />                                             antibiotic resistance gene, i.e. selectable marker, flanking sequences target <br />                                             recombination results replacement endogenous gene selectable <br />                                             marker. The creation null mutant, i.e. cell alleles eliminated, a <br />                                             definitive way identify non-essential genes. Conditional <span id='am-317' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-318' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-319' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-320' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-322' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-323' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-326' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-333' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-335' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-340' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-346' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-347' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-356' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-364' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-369' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-371' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-372' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-378' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-379' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-383' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-384' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-388' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-394' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi) [1], by <br />                                             expression target gene repressed mRNA destruction tetracycline(tet)- <br />                                             dependant manner, commonly used T. brucei assess gene function and <br />  <br />  <br />                            1 <br />                             Corresponding author. Seattle Biomedical Research Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA 98109-5219. <br />                            ken.stuart@seattlebiomed.org, Tel: 206-256-7302. <br />                             Merritt Stuart                                                                                            Page 2 <br />  <br />  <br />                                                 essentiality. RNAi cell line production entails cloning single RNAi construct and <br />                                                 single transfection step appropriate cell line. The ability efficiently generate <br />                                                 RNAi cell lines led systematic use assess genes chromosome [2] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 genome-wide analysis genes using deep sequencing population RNAi cell <br />                                                 lines [3]. An additional advantage RNAi approach mRNAs nearly <br />                                                 identical paralogs simultaneously targeted single construct. However, RNAi <br />                                                 disadvantages sufficiently reduce mRNA levels generate a <br />                                                 definitive <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> off-target effects, i.e. degradation mRNA genes <br />                                                 intentionally targeted. Little known off-target RNAi effects T. <br />                                                 brucei, however, genetic approaches used verify RNAi acting on-target <br />                                                 [4]. We prepared null cell lines knocking endogenous alleles cells a <br />                                                 &#226;&#8364;&#339;conditional null&#226;&#8364;? cell line knocking endogenous alleles cells tet- <br />                                                 regulatable copy target gene&#226;&#8364;&#8482;s coding DNA sequence (CDS) determine the <br />                                                 essentiality protein kinases. Expression knockdown robust conditional <br />                                                 nulls cell lines cell lines widely used preparation <br />                                                 requires multiple transfections cloning steps. However, improved efficiency of <br />                                                 production minimizing need prepare plasmid constructs improving <br />                                                 transfection selection conditions. <br />  <br />                                                 We employed efficient PCR approach make gene KO DNA constructs instead a <br />                                                 sequential PCR/cloning approach (e.g. [5&#226;&#8364;&#8220;9]) time consuming has <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 pitfalls reflect limitations restriction enzyme digestion, DNA fragment <br />                                                 purification, ligation efficiency. A PCR approach used directly produce the <br />                                                 DNA constructs transfection single PCR reaction drug resistance markers with <br />                                                 long oligos (~100 nucleotides) contain targeting sequences gene-specific KOs (e.g. <br />                                                 [10] http://tryps.rockefeller.edu/trypsru2_genetics.html). We instead employed &#226;&#8364;&#339;fusion <br />                                                 PCR&#226;&#8364;? approach generate KO constructs sizeable homologous targeting sequences <br />                                                 (Fig. 1) use long oligos PCR adds significant cost effectively limits the <br />                                                 <span id='am-3' about='xsp:length' typeof='owl:Thing'>length</span> homologous targeting region. This targeting region limit affect frequency <br />                                                 homologous recombination shown shorter targeting sequences result <br />                                                 lower recombination frequency T. brucei [11] seen organisms. <br />                                                 Hence, used long (~500 nt) targeting sequences potentially provide greater <br />                                                 recombination frequency, greater frequency transfection. These larger targeting <br />                                                 regions used fusion PCR approach enhance efficiency transfection <br />                                                 construct production. <br />  <br />                                                 The fusion PCR method used (Fig. 1) adapted used systems <br />                                                 (e.g. [12, 13]). Multiple PCR reactions used rapidly, inexpensively, effectively <br />                                                 generate DNA direct use transfections. Two separate PCR reactions used <span id='am-4' about='protege:TO' typeof='owl:Thing'>to</span> <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 amplify 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; targeting sequences T. brucei genomic DNA gene. The inner <br />                                                 oligos contain sequence complementary outer sequences selectable <br />                                                 marker PCR amplified bulk plasmid DNA gel purified. The 5&#226;&#8364;&#178;, 3&#226;&#8364;&#178; <br />                                                 selectable marker PCR products combined removal PCR primers using <br />                                                 commercial spin column (Qiagen) amplified PCR reaction produces <br />                                                 fusion PCR product transfection. Six unique oligos needed create fusion <br />                                                 product KO allele (Fig 1). For 1st allele inner oligos (oligos B, D) <br />                                                 contain sequences complement 1st selectable marker, outer oligos <br />                                                 (oligos A, F) provide amplification ~500 nts targeting sequence flanking gene <br />                                                 CDS, oligos (G, H) nested (i.e. internal oligos A F) specificity <br />                                                 create fusion PCR product used transfection. Two additional <br />                                                 oligos (oligos C, E) needed contain sequences complementary 2nd <br />                                                 selectable marker generate PCR product used fusion PCR to <br />  <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                               Page 3 <br />  <br />  <br />                                                 generate construct KO 2nd allele. The original outer oligos the <br />                                                 nested PCR (i.e. oligos A, F, G, H). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 The fusion PCR transfection constructs alleles manner the <br />                                                 targeting sequences. This result construct 2nd allele KO recombining <br />                                                 site 1st allele KO. However use drugs combination select <br />                                                 cells making approach suitable high throughput studies. Nevertheless, <br />                                                 recombination 2nd allele KO construct site 1st allele KO (and does) <br />                                                 occur. This eliminate 2nd endogenous allele insert site 2nd <br />                                                 selectable marker retain replace 1st selectable marker. This be <br />                                                 averted detailed supplementary material using oligo pairs internal A, <br />                                                 B D, F PCR amplify targeting sequences 2nd selectable marker. This <br />                                                 results need additional oligos awareness possible consequences to <br />                                                 adjacent genes (e.g. deletion important regulatory coding sequences). Thus, minimally <br />                                                 eight, maximally ten, oligos needed KO alleles, the <br />                                                 number used long oligo KO approach. However, total cost ten <br />                                                 oligos fraction cost longer ones smaller size. Currently total <br />                                                 reagents costs fusion PCR 3&#226;&#8364;&#8220;4 times single PCR method using <br />                                                 long oligos substantially greater cost long oligos. In addition, the <br />                                                 larger flanking gene targeting regions fusion PCR products provide higher <br />                                                 recombination transfection efficiencies. The oligos designed similar <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 annealing temperatures PCR products generated same <br />                                                 conditions. This PCR protocol scaled 96-well format enables <br />                                                 simultaneous production PCR products KO 12&#226;&#8364;&#8220;24 genes (see supplementary <br />                                                 materials details). More PCR products produced time (e.g. 48&#226;&#8364;&#8220;96 genes) <br />                                                 subsequent steps transfection, cell maintenance confirmation desired <br />                                                 transfections effectively limit production 24 gene KOs time person. <br />  <br />                                                 Fusion PCR products prepared used KO target genes T. brucei attempt to <br />                                                 create null mutants, i.e. eliminate endogenous alleles, 20 predicted protein kinases. <br />                                                 The creation null mutants definitively demonstrate eliminated gene not <br />                                                 essential viability. A conditional null mutant produced null mutants not <br />                                                 obtained. The protein kinases chosen primarily members Sterile (STE) and <br />                                                 Other protein kinase groups thoroughly studied genetically T. brucei. <br />                                                 Null mutants generated higher-throughput fusion PCR transfection method <br />                                                 using different selectable markers sequentially KO endogenous copies target <br />                                                 genes (see supplementary materials KO schematic). These constructs designed to <br />                                                 precisely delete target gene start stop codon. One endogenous allele was <br />                                                 eliminated transfecting purified fusion PCR products electroporation bloodform <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 (BF) T. brucei single marker 427 cells (SM427) [14]. The SM427 cell line expresses T7 <br />                                                 polymerase Tet repressor proteins &#206;&#178; tubulin locus (maintained NEO <br />                                                 selectable marker) control tet conditional expression transgenes [14]. The <br />                                                 electroporation PCR fusion product using approximately 2&#195;&#8212;107 mid log <br />                                                 phase SM427 cells outlined supplementary materials. Several conditions affect <br />                                                 transfection efficiency generation KO cell lines. These include amount <br />                                                 quality DNA used, length targeting sequences, number, growth <br />                                                 phase strain cells, transfection device settings used, selectable <br />                                                 markers, concentrations plating conditions used selection for <br />                                                 transfectants. Many variables examined previously ([11, 15]) few <br />                                                 addressed herein. We choice transfection device used greatly affects <br />                                                 transfection frequency ([16], http://tryps.rockefeller.edu/ <br />                                                 trypsru2_protocols_index.html). More importantly, drug resistance <br />  <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                              Page 4 <br />  <br />  <br />                                                 markers used concentrations drugs used selection critical reliably <br />                                                 obtaining KO, especially null, cell lines. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 An average 58 independent clones (determined limiting dilution) 1st allele <br />                                                 knocked obtained ~2&#195;&#8212;107 cells using ~200&#226;&#8364;&#8220;600ng PCR fusion product. <br />                                                 For 20 genes analyzed, range order magnitude. No correlation was <br />                                                 observed number clones obtained PCR product used <br />                                                 200ng, length target gene&#226;&#8364;&#8482;s ORF kb (data shown). <br />                                                 Transfections similar conditions using blasticidin, puromycin, phleomycin <br />                                                 selectable markers (BSD, PAC, BLE) resulted 1st allele KOs numbers of <br />                                                 clones obtained different genes different drug concentrations not <br />                                                 analyzed. Success rates 2nd allele KOs similar conditions 15&#226;&#8364;&#8220;140 fold lower. <br />                                                 Success rates 2nd allele KOs genes lower tet-regulatable <br />                                                 copy expressed (data shown). Thus lower success rates 2nd allele KOs be <br />                                                 explained solely response elimination gene expression. Electroporation using <br />                                                 Amaxa Nucleofection device, higher transfection efficiency BTX <br />                                                 device ([16], http://tryps.rockefeller.edu/trypsru2_protocols_index.html), resulted a <br />                                                 greater number 2nd allele KOs (7&#226;&#8364;&#8220;30 fold more). The lower number transfectants of <br />                                                 2nd versus 1st allele KOs increased selection consequence absence <br />                                                 allele, potential effects expression genes (e.g. cluster) of <br />                                                 gene KO, competition recombination 1st allele KO locus, and/or the <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 effect using multiple antibiotics. Competition recombination reduced not <br />                                                 eliminated using sequences fusion PCR product 2nd allele been <br />                                                 eliminated 1st allele KO outlined (see supplementary material). <br />  <br />                                                 The choice selectable marker, drug concentration, conditions selection were <br />                                                 significant variables affecting frequency allele KO clones obtained, <br />                                                 especially 2nd allele KO (see supplementary material). Reducing drug concentrations <br />                                                 generally used selection T. brucei (5 &#206;&#188;g/ml hygromycin, 5 &#206;&#188;g/ml <br />                                                 blasticidin, 0.1 &#206;&#188;g/ml puromycin, 2.5 &#206;&#188;g/ml phelomycin) (http://tryps.rockefeller.edu/ <br />                                                 trypsru2_genetics.html) omitting drug selection time resulted a <br />                                                 greater frequency obtaining KO cell clones (see supplementary material). This suggests <br />                                                 expression levels drug resistance markers governed target genes <br />                                                 endogenous UTRs ideal selection depending selectable marker. In <br />                                                 support this, providing selectable marker gene UTRs support <br />                                                 higher levels expression provided wider window drug selection level of <br />                                                 expression endogenous gene UTRs limiting, lower levels of <br />                                                 expression (see supplementary material). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 To verify desired gene KOs, genomic DNA clones obtained 1st 2nd allele <br />                                                 transfection genotyped using diagnostic oligos qRT-PCR and, cases, by <br />                                                 PCR gel analysis. All clones obtained attempting KO 1st allele (with HYG) <br />                                                 of 20 protein kinases showed loss endogenous coding sequence (CDS) <br />                                                 copy qRT-PCR (Fig. 2). Attempts KO 2nd allele (with BSD PAC) 20 1st <br />                                                 allele KO cell lines resulted 46/47 clones (multiple clones genes) both <br />                                                 endogenous CDSs absent (Fig. 2, data shown). However, unable to <br />                                                 knockout second CRK12 allele (see below). We did analyze cell line <br />                                                 resistant selectable markers copy target gene CDS. <br />                                                 Several KO cell lines examined PCR using oligos outside targeting region <br />                                                 subsequent gel analysis showed presence bands consistent replacement of <br />                                                 target CDS selectable markers (Fig. 2B, data shown). These data suggest <br />                                                 approach described infrequently generate cell lines resistant <br />                                                 selectable marker contain desired 2nd allele KO events as <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                                Page 5 <br />  <br />  <br />                                                 mis-targeting gene duplication. This minimizes time needed confirm identity of <br />                                                 desired clones transfection. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Identification genes essential viability order determine their <br />                                                 function potential drug targets. Stable null cell lines obtained such <br />                                                 genes genetic compensation. Attempts knock 2nd endogenous <br />                                                 allele essential gene result viable stable cell lines multiple <br />                                                 attempts, repeatedly observed (data shown), result in <br />                                                 unintended genetic changes. Stable cell lines obtained attempts resistant <br />                                                 drugs encoded 1st 2nd KO selectable markers retain copy gene <br />                                                 CDS mis-integrating selectable marker off-target locus integrating the <br />                                                 targeted locus loss resident allele (e.g. result gene duplication <br />                                                 event). For example, CK1.2 (Tb927.5.800) strong growth defect RNAi BFs and <br />                                                 attempts create null cell lines unsuccessful suggesting essential <br />                                                 [8]. Our multiple attempts create null cell lines CK1.2 resulted cell lines that <br />                                                 contained resistance markers contained copy CK1.2 CDS, consistent <br />                                                 gene essential growth BF T. brucei (data shown). <br />  <br />                                                 Conditional null cell lines generated study genes essential viability. By <br />                                                 approach, tet-regulatable copy gene CDS inserted transcriptionally <br />                                                 silent rRNA intergenic locus SM427 T. brucei cells prior KO endogenous <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 alleles. For efficiency, tet-regulatable copy introduced cells 1st <br />                                                 allele knocked simultaneously parallel attempts generate null <br />                                                 mutant. The 2nd endogenous allele knocked fusion PCR product the <br />                                                 2nd allele KO selection performed media contains tet ensure expression the <br />                                                 regulatable copy rRNA intergenic region. Proper gene insertion assayed PCR as <br />                                                 indicated tet-regulation assayed monitoring cell growth presence <br />                                                 (gene expressed) absence tet (gene repressed) monitoring mRNA knockdown with <br />                                                 qPCR northern blot. Expression regulatable copy monitored western <br />                                                 analysis antibody available protein epitope tag has <br />                                                 fused regulatable copy. In addition, level mRNA protein knockdown <br />                                                 controlled moderate range adjusting level tet cell grown <br />                                                 media. <br />  <br />                                                 The tet-regulatable copy gene CDS cloned vectors that <br />                                                 widely available (see http://www.zbh.uni-heidelberg.de/clayton/vectors.html, http:// <br />                                                 tryps.rockefeller.edu/trypsru2_plasmids.html references supplementary materials). <br />                                                 Insertion CDS appropriate tet-regulatable vector performed by <br />                                                 traditional ligation cloning restriction enzyme sites designed CDS PCR oligos or <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 efficiently vitro recombination using Gateway (Invitrogen) the <br />                                                 recombinase-specific sequence tails added oligos amplify CDS. To expedite <br />                                                 cloning regulatable transgenes simultaneously, modified commonly <br />                                                 used regulatable expression vector (pLEW100v5) gene CDS inserted via <br />                                                 vitro recombination (see supplementary materials). <br />  <br />                                                 Using scheme outlined supplementary materials, created conditional <br />                                                 null cell lines BF procyclic form (PF) T. brucei including CDC2-related <br />                                                 kinase CRK12 (Tb11.01.4130) BF cells (Fig. 3) previously shown to <br />                                                 growth defect RNAi [17]. This cell line created SM427 cells which <br />                                                 express tet repressor protein necessary regulation CDS allele the <br />                                                 rRNA locus. For cell line, fusion PCR products constructed described were <br />                                                 used KO endogenous alleles Gateway version pLEW100v5 used to <br />                                                 produce tet-regulatable copy (Fig. 3A). The genotype cell line verified by <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                                               Page 6 <br />  <br />  <br />                                                 qRT-PCR genomic DNA template (Fig. 3B). Growth cells monitored over <br />                                                 days media containing tet (regulatable CRK12 on) lacking tet (regulatable <br />                                                 CRK12 off) showed strong growth phenotype cells regulatable copy <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 longer expressed (Fig. 3C). Growth resumed days presumably loss <br />                                                 repression regulatable allele rRNA locus means have <br />                                                 resulted growth recovery. However, similar loss repression seen other <br />                                                 conditional null cell lines [18&#226;&#8364;&#8220;20] shown correspond mutations that <br />                                                 result loss tet repressor coding sequences [19]. <br />  <br />                                                 The method described supplementary materials enable efficient analysis of <br />                                                 gene essentiality gene function T. brucei. It does substituting PCR gene <br />                                                 cloning substantial extent preparing numerous transfection constructs and <br />                                                 performing multiple transfections simultaneously. In way numerous gene KO cell lines <br />                                                 conditional cell lines rapidly generated. In addition, variations described that <br />                                                 increase utility conditional null cell lines. We selectable <br />                                                 drug markers used selection conditions important factors obtaining KO cells <br />                                                 lines (see supplementary materials). The number selectable drug markers used for <br />                                                 cell line construction reduced using KO method. One approach to <br />                                                 employ loss-of-heterozygosity increasing drug pressure select recombinants in <br />                                                 inserted drug marker single allele gene KO converts wild type allele <br />                                                 mitotic recombination eliminating it. This approach used infrequently <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 T. brucei gene conversion occurs frequently association antigenic <br />                                                 variation. Selectable markers excised integration allow reuse in <br />                                                 subsequent transfectants. This accomplished generating KO cell lines PCR <br />                                                 products contain positive selectable marker (i.e. HYG, PAC, BSD, BLE) fused a <br />                                                 negative selectable marker (HSVTK CDS) flanked loxP sites. Excision be <br />                                                 accomplished transient transfection Cre recombinase selection HSVTK <br />                                                 protein addition Ganciclovir media (see references details supplementary <br />                                                 materials). <br />  <br />                                                 Overall, used fusion PCR-based KO technique stringently assess gene essentiality in <br />                                                 BF T. brucei producing null conditional null cell lines. Obtaining 19 null cell lines for <br />                                                 protein kinases illustrates efficiency 6 nulls protein kinases BF T. brucei <br />                                                 reported date [5&#226;&#8364;&#8220;9]. The methods used provide alternative greater <br />                                                 stringency conditional RNAi analysis essential genes. Additional <br />                                                 methodological details provided supplementary material. <br />  <br />                               Supplementary Material <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                                 We thank Ngoc Tran technical assistance Jef Boeke oligo ordering advice. This work supported by <br />                                                 National Institutes Health grant AI078962 studies initiated support National Institutes <br />                                                 Health grant AI075641. <br />  <br />  <br />                               References <br />                                                 1. Kolev NG, Tschudi C, Ullu E. RNA interference protozoan parasites: achievements and <br />                                                    challenges. Eukaryot Cell. 2011; 10:1156&#226;&#8364;&#8220;63. [PubMed: 21764910] <br />                                                 2. Subramaniam C, Veazey P, Redmond S, Hayes-Sinclair J, Chambers E, Carrington M, et al. <br />                                                    Chromosome-wide analysis gene function RNA interference african trypanosome. <br />                                                    Eukaryot Cell. 2006; 5:1539&#226;&#8364;&#8220;49. [PubMed: 16963636] <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                                  Page 7 <br />  <br />  <br />                                                 3. Alsford S, Turner DJ, Obado SO, Sanchez-Flores A, Glover L, Berriman M, et al. High-throughput <br />                                                    phenotyping using parallel sequencing RNA interference targets African trypanosome. <br />                                                    Genome Res. 2011; 21:915&#226;&#8364;&#8220;24. [PubMed: 21363968] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 4. Ringpis GE, Lathrop RH, Aphasizhev R. iCODA: RNAi-based inducible knock-in in <br />                                                    Trypanosoma brucei. Methods Mol Biol. 2011; 718:23&#226;&#8364;&#8220;37. [PubMed: 21370040] <br />                                                 5. Domenicali Pfister D, Burkard G, Morand S, Renggli CK, Roditi I, Vassella E. A Mitogen-activated <br />                                                    protein kinase controls differentiation bloodstream forms Trypanosoma brucei. Eukaryot Cell. <br />                                                    2006; 5:1126&#226;&#8364;&#8220;35. [PubMed: 16835456] <br />                                                 6. Jensen BC, Kifer CT, Parsons M. Trypanosoma brucei: Two mitogen activated protein kinase <br />                                                    kinases dispensable growth virulence bloodstream form. Exp Parasitol. 2011; <br />                                                    128:250&#226;&#8364;&#8220;5. [PubMed: 21396364] <br />                                                 7. Muller IB, Domenicali-Pfister D, Roditi I, Vassella E. Stage-specific requirement mitogen- <br />                                                    activated protein kinase Trypanosoma brucei. Mol Biol Cell. 2002; 13:3787&#226;&#8364;&#8220;99. [PubMed: <br />                                                    12429824] <br />                                                 8. Urbaniak MD. Casein kinase 1 isoform 2 essential bloodstream form Trypanosoma brucei. <br />                                                    Mol Biochem Parasitol. 2009; 166:183&#226;&#8364;&#8220;5. [PubMed: 19450734] <br />                                                 9. Vassella E, Kramer R, Turner CM, Wankell M, Modes C, van den Bogaard M, et al. Deletion a <br />                                                    novel protein kinase PX FYVE-related domains increases rate differentiation of <br />                                                    Trypanosoma brucei. Mol Microbiol. 2001; 41:33&#226;&#8364;&#8220;46. [PubMed: 11454198] <br />                                                 10. Gaud A, Carrington M, Deshusses J, Schaller DR. Polymerase chain reaction-based gene <br />                                                      disruption Trypanosoma brucei. Mol Biochem Parasitol. 1997; 87:113&#226;&#8364;&#8220;5. [PubMed: 9233680] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 11. Barnes RL, McCulloch R. Trypanosoma brucei homologous recombination dependent on <br />                                                      substrate length homology, displays differential dependence mismatch repair as <br />                                                      substrate length decreases. Nucleic Acids Res. 2007; 35:3478&#226;&#8364;&#8220;93. [PubMed: 17478508] <br />                                                 12. Szewczyk E, Nayak T, Oakley CE, Edgerton H, Xiong Y, Taheri-Talesh N, et al. Fusion PCR and <br />                                                      gene targeting Aspergillus nidulans. Nat Protoc. 2006; 1:3111&#226;&#8364;&#8220;20. [PubMed: 17406574] <br />                                                 13. Noble SM, Johnson AD. Strains strategies large-scale gene deletion studies diploid <br />                                                      human fungal pathogen Candida albicans. Eukaryot Cell. 2005; 4:298&#226;&#8364;&#8220;309. [PubMed: 15701792] <br />                                                 14. Wirtz E, Leal S, Ochatt C, Cross GA. A tightly regulated inducible expression for <br />                                                      conditional gene knock-outs dominant-negative genetics Trypanosoma brucei. Mol <br />                                                      Biochem Parasitol. 1999; 99:89&#226;&#8364;&#8220;101. [PubMed: 10215027] <br />                                                 15. Wirtz E, Hartmann C, Clayton C. Gene expression mediated bacteriophage T3 T7 RNA <br />                                                      polymerases transgenic trypanosomes. Nucleic Acids Res. 1994; 22:3887&#226;&#8364;&#8220;94. [PubMed: <br />                                                      7937108] <br />                                                 16. Burkard G, Fragoso CM, Roditi I. Highly efficient stable transformation bloodstream forms of <br />                                                      Trypanosoma brucei. Mol Biochem Parasitol. 2007; 153:220&#226;&#8364;&#8220;3. [PubMed: 17408766] <br />                                                 17. Mackey ZB, Koupparis K, Nishino M, McKerrow JH. High-throughput analysis RNAi <br />                                                      library identifies novel kinase targets Trypanosoma brucei. Chem Biol Drug Des. 2011; 78:454&#226;&#8364;&#8220; <br />                                                      63. [PubMed: 21668652] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 18. Martin KL, Smith TK. The glycosylphosphatidylinositol (GPI) biosynthetic pathway of <br />                                                      bloodstream-form Trypanosoma brucei dependent novo synthesis inositol. Mol <br />                                                      Microbiol. 2006; 61:89&#226;&#8364;&#8220;105. [PubMed: 16824097] <br />                                                 19. Roper JR, Guther ML, Milne KG, Ferguson MA. Galactose metabolism essential African <br />                                                      sleeping sickness parasite Trypanosoma brucei. Proc Natl Acad Sci U S A. 2002; 99:5884&#226;&#8364;&#8220;9. <br />                                                      [PubMed: 11983889] <br />                                                 20. Young SA, Smith TK. The essential neutral sphingomyelinase involved trafficking the <br />                                                      variant surface glycoprotein bloodstream form Trypanosoma brucei. Mol Microbiol. <br />                                                      2010; 76:1461&#226;&#8364;&#8220;82. [PubMed: 20398210] <br />  <br />  <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                         Page 8 <br />  <br />  <br />                                                                                              Highlights <br />                                                     &#226;&#8364;&#162;     CRK12 essential protein kinase BF T. brucei. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                     &#226;&#8364;&#162;     19 protein kinases essential bloodstream form T. brucei. <br />                                                     &#226;&#8364;&#162;     Efficient methods producing transgenic T. brucei cell lines. <br />                                                     &#226;&#8364;&#162;     Use fusion PCR, Gateway system, improved selection conditions. <br />                                                     &#226;&#8364;&#162;     Supplementary material methodological details protocols. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                          Page 9 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Figure 1. Schema generation transfection constructs <br />                                                 Fusion PCR method generates <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-241' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-247' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-255' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-258' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-261' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-263' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-267' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-268' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-275' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-308' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span>gene knockout</span> (KO) constructs. Step 1: gene-specific 5&#226;&#8364;&#178; <br />                                                 3&#226;&#8364;&#178; targeting sequences alleles amplified separate PCRs using different <br />                                                 oligonucleotides (oligos). Step 2: The 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; targeting fragments allele fused <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 PCR coding DNA sequence (CDS) respective selectable marker (SM) <br />                                                 amplified plasmid stock. Complementary sequences designed the <br />                                                 termini oligos illustrated nested oligos G H provide specific <br />                                                 amplification fusion PCR product. Approximately 25&#226;&#8364;&#8220;50ng 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; targeting <br />                                                 sequences drug resistance CDS PCR products combined fused PCR <br />                                                 amplification. The fusion PCR products verified purified agarose gel and <br />                                                 recovered Qiagen gel extraction kit. Fusion PCR protocols oligo sequences are <br />                                                 detailed supplementary material. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                         Page 10 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Figure 2. Genotyping putative KO cell lines <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 A. qRT-PCR analysis genomic DNA isolated putative 1st allele KO 2nd allele <br />                                                 KO (putative null) cell lines. For cell line, genomic DNA isolated <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br />                                                 approximately 1&#195;&#8212;107 cells DNeasy Blood &amp; Tissue Kit (Qiagen). QRT-PCR was <br />                                                 performed triplicate SsoFast EvaGreen Supermix With Low ROX (BioRad) a <br />                                                 7500 Real-Time PCR System (Applied Biosystems). Oligos qRT-PCR designed <br />                                                 using Primer3Plus (sequences given supplementary material). Tert used internal <br />                                                 control. All 1st allele KO cell lines (n=19) showed loss copy qRT-PCR. Most 2nd <br />                                                 allele KO cell lines (putative nulls) showed loss copies qRT-PCR. Genotypically <br />                                                 null cell lines obtained 19 genes, lines Tb11.02.4860 <br />                                                 (CAMKK) retained copy target CDS (* RT &lt; 0.0001, ** RT &lt; 0.005, &#194;&#165; no <br />                                                 amplification, # target amplification). B. Example genotyping Tb927.10.14780 <br />                                                 null cell line PCR using oligos outside targeting regions subsequent gel <br />                                                 analysis showed presence novel bands consistent replacement target <br />                                                 CDS&#226;&#8364;&#8482;s selectable marker CDSs. <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                         Page 11 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Figure 3. CRK12 conditional null cell line created fusion PCR Gateway approach <br />                                                 A. Fusion PCR products used KO CRK12 endogenous alleles HYG and <br />                                                 BSD. The Gateway cloning approach used generate tet-regulatable copy of <br />                                                 CRK12 transfection. To clone tet-regulatable copy CRK12, CRK12 CDS <br />                                                 (Tb11.01.4130) PCR amplified SM427 genomic DNA using Phusion polymerase <br />                                                 (NEB) oligos KO_078(CRK12)GWF KO_078(CRK12)GWR, contain attB <br />                                                 recombination sequences Gateway cloning. The product gel purified cloned <br />                                                 pDONR221 using BP Clonase II (Invitrogen). The proper clone verified by <br />                                                 restriction enzyme digestion DNA sequencing. The resultant Entry Clone (pCM013) <br />                                                 recombined Gateway compatible version pLEW100v5 vector <br />                                                 (pCM038) proper clone verified restriction enzyme digestion sequencing. <br />                                                 The resultant plasmid (pCM092) linearized NotI prior transfection T. brucei <br />  <br />                                                 Mol Biochem Parasitol. Author manuscript; available PMC 2014 January 10. <br />                             Merritt Stuart                                                                                        Page 12 <br />  <br />  <br />                                                 generate cell line tet-dependent CRK12 expression rRNA intergenic <br />                                                 region. B. QRT-PCR verification CRK12 conditional null cell line. Oligos amplifying a <br />                                                 region CRK12 CDS copy CDS present (tet-regulatable copy) and <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 sets oligos amplify 5&#226;&#8364;&#178;/CDS 3&#226;&#8364;&#178;/CDS regions specific endogenous allele of <br />                                                 CRK12 absence endogenous CRK12 CDS (* RT &lt; 0.0005). The tet-regulatable <br />                                                 CRK12 different 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; UTRs endogenous alleles. C. Growth curve <br />                                                 CRK12 conditional null cell line shows growth rate inhibition withdraw tet. <br />                                                 CRK12 (Tb11.01.4130) conditional null cells maintained sequential dilutions of <br />                                                 media containing tet maintain cells mid-log phase growth. CRK12 conditional null cell <br />                                                 cultures densities 7&#195;&#8212;105 &#226;&#8364;&#8220; 1&#195;&#8212;106 parasites/ml used inocula growth curves. <br />                                                 The cells spun washed twice media lacking tet wash tet 5&#195;&#8212;104 <br />                                                 parasites/ml diluted 20 ml split 10 ml cultures (+tet &#226;&#710;&#8217;tet). <br />                                                 Cultures conditional null copy maintained media 1 &#206;&#188;g/ml tet maintain <br />                                                 expression. Cells Incubat <br /> </body></html>